PMID: 7539317Apr 1, 1995Paper

Clinical tumour markers in lung cancer

European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)
J Niklinski, M Furman

Abstract

Within the past few years, the measurement of serum and tissue markers has had an increasing influence on clinical decisions about initial treatment and follow-up. Lung cancer illustrates the types and importance of these various markers. This review presents data concerning the most studied and interesting markers in non-small cell (NSCLC) and small cell lung cancer (SCLC). CEA, TPA, SCC-Ag, CYFRA 21-1, ferritin, CA19-9, CA50, CA242, H-K-N-ras mutations and p53 mutation seem to be the most prolific in NSCLC, while NSE, BN/GRP, CK-BB, NCAM, IL-2R, IGF-I, transferrin, ANP, mAb (cluster 5), Le-y and c-N-L-myc mutation are markers in SCLC patients. Some of these serum markers might be useful adjuncts for monitoring response to therapy, including early detection of tumour reactivation to allow curative therapy and rapid detection of treatment failure to allow change of the regimen. The study of these markers also may lead to a better understanding of the biological characteristics of lung cancer. The information derived from these biological studies represents the most promising avenue towards new treatment strategies, as well as attempts at secondary prevention.

Citations

Nov 27, 2001·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·J NiklińskiL Chyczewski
Feb 27, 1999·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·J LaudanskiJ Niklinski
Apr 8, 1998·International Journal of Radiation Oncology, Biology, Physics·R KomakiN G Ordonez
Nov 1, 1996·Seminars in Oncology Nursing·K V Harwood
May 29, 2000·Pathophysiology : the Official Journal of the International Society for Pathophysiology·Y HirotaH Nakazawa
Feb 21, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·T PainbeniP Allain
Feb 16, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H L McLeodJ Cassidy
Jul 16, 2003·International Immunopharmacology·John W Hadden
Aug 20, 2005·American Journal of Respiratory and Critical Care Medicine·Li ZhongEdward A Hirschowitz
Aug 6, 2000·Clinical Chemistry and Laboratory Medicine : CCLM·J SchneiderH J Woitowitz
Oct 20, 2005·Clinical Chemistry and Laboratory Medicine : CCLM·Laurent RamontFrançois-Xavier Maquart
Mar 21, 2002·Expert Review of Molecular Diagnostics·G Buccheri, D Ferrigno
Nov 3, 2012·Journal of Biomedicine & Biotechnology·Angels Díaz-RamosRoser López-Alemany
Mar 27, 2009·Journal of Cancer Research and Clinical Oncology·Hong HeYanmin Liu
Jul 15, 2015·Biosensors & Bioelectronics·Jong Uk LeeSang Jun Sim
Jul 4, 2001·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·J NiklinskiE Pluygers
Jun 1, 2000·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·W NiklinskaJ Niklinski
Dec 4, 2015·Mass Spectrometry Reviews·Huiliang YangYuquan Wei
Mar 19, 2016·Biochimica Et Biophysica Acta·Andreia Almeida, Daniel Kolarich
Feb 1, 2009·Proteomics. Clinical Applications·Jing-Jing LiDong Xie
Dec 27, 2008·Analytica Chimica Acta·Yuanjin ZhaoZhongze Gu
Jul 16, 2013·Human Vaccines & Immunotherapeutics·Kurt Whittemore, Kathryn Sykes
Jun 20, 2013·Clinica Chimica Acta; International Journal of Clinical Chemistry·Nicole V TolanStefan K G Grebe
Oct 1, 1995·Respiratory Medicine·D Ferrigno, G Buccheri
Jun 21, 2012·Biochemical and Biophysical Research Communications·Yibing YaoQinghua Zhou
Jan 13, 2006·Molecular & Cellular Proteomics : MCP·Chia-Hsin ChanLu-Ping Chow
Dec 19, 2003·Nature Reviews. Cancer·Michael A Hollingsworth, Benjamin J Swanson
Aug 20, 2017·Journal of Clinical Pathology·Swarnendu BagJyotirmoy Chatterjee
Aug 1, 1997·Breast Cancer Research and Treatment·M Reiss, M H Barcellos-Hoff
Feb 20, 2016·Oncology Letters·Kunihiko MiyazakiNobuyuki Hizawa
Jan 4, 2017·BioMed Research International·Stefan HoldenriederFarshid Dayyani

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.